SynAct Pharma AB (8F8)
Market Closed
10 Aug, 20:00
XFRA 
€
1. 69
-0.03
-1.9699%
€
88.01M Market Cap
- P/E Ratio
- Div Yield
515 Volume
-1.55 Eps
€ 1.73
Previous Close Want to track 8F8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SynAct Pharma AB (8F8) Statistics
Valuation metrics
Market Cap 88.01M
Enterprise value 35.82M
Trailing P/E (ttm) -0.74
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) -
Price/Book (mrq) 0.44
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.31
Overview
Shares outstanding 53.33M
Float 32.87M
Shares short -
% Held by insiders 0.3%
% Held by institutions 0.17%
Average volume (10 days) 86
Average volume (90 days) 108
Price summary
52-Week low 0.97
52-Week high 2.32
Beta 1.01
50-Day moving average 1.85
200-Day moving average 1.83
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.3%
Return on equity -0.58%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -110.83M
Diluted EPS (ttm) -0.2
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 1.21M
Total Debt/Equity (mrq) 0.71
Current ratio (mrq) 3.31%
Book value per share (mrq) 3.65
Cash Flow
Cash flow statement -116.54M
Levered free cash flow (LFCF) -5.78M
